Recent insider selling at Frontage Holdings, especially by the CEO, may worry investors. Despite insiders owning significant shares, the absence of insider buying in the past year and recent selling activity suggest caution before investing.

Frontage Holdings' P/E remains high despite price drop, indicating investors' belief in the company's prosperous future and superior earnings outlook.

Frontage CEO lauds Gao's skillset and experience in biotech and CRO, sees him as key to enhance client services in Asia Pacific operations.